Physician profile
Steven R Mindrup
NPI 1447298005
$8,300.77
in general payments reported to CMS, 2019-2025
36 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,237 · 2020: $286 · 2021: $604 · 2022: $2,206 · 2023: $480 · 2024: $313 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,599.95 | 2019-2020 | |
| Intuitive Surgical, INC. | $1,247.83 | 2019 | |
| Valencia Technologies Corporation | $1,240.47 | 2022 | |
| Neotract INC. | $1,199.36 | 2019-2020 | |
| 180 Medical, INC. | $551.69 | 2019-2024 | Gentlecath, Cure Catheter, Gentlecath Glide |
| Astellas Pharma US INC | $318.04 | 2021-2024 | Xtandi |
| Teleflex LLC | $282.82 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $214.59 | 2019-2025 | Axonics |
| Pfizer INC. | $205.92 | 2019-2025 | |
| Abbvie INC. | $189.56 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $167.71 | 2019-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $113.82 | 2019-2023 | |
| Axonics, INC. | $103.40 | 2021-2023 | Bulkamid, Axonics |
| Medtronic, INC. | $87.25 | 2022 | |
| Palette Life Sciences, INC. | $77.05 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $75.43 | 2023-2024 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $72.39 | 2019-2023 | Erleada |
| Urogen Pharma, INC. | $69.95 | 2022-2025 | |
| Coloplast Corp | $69.70 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $42.65 | 2023-2024 | Orgovyx, Gemtesa |
| C. R. Bard, INC. & Subsidiaries | $36.70 | 2025 | Aptra |
| Verity Pharmaceuticals INC. | $36.10 | 2022-2023 | Trelstar |
| Myovant Sciences INC. | $32.38 | 2021 | |
| Novartis Pharmaceuticals Corporation | $32.05 | 2024 | |
| Rochester Medical Corporation | $29.42 | 2022 | |
| Cook Medical LLC | $29.04 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $28.46 | 2022-2023 | Edex, Xiaflex, Aveed |
| Civco Medical Instruments | $23.37 | 2024 | |
| Progenics Pharmaceuticals, INC. | $21.34 | 2023 | Pylarify |
| Travere Therapeutics, INC. | $16.60 | 2019 | |
| Endo USA, INC. | $15.37 | 2025 | Xiaflex |
| Allergan, INC. | $15.20 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.58 | 2024 | |
| Telix Pharmaceuticals | $13.96 | 2023 | Illuccix |
| Vertex Pharmaceuticals Incorporated | $13.52 | 2025 | |
| Olympus America INC. | $13.10 | 2023 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Mindrup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.